SlideShare a Scribd company logo
1 of 21
The effects of a fibrotic
microenvironment on the
proliferation of prostate cancer cells.
Brad Christman
Macoska Lab
Background
• Prostate is a part of the male reproductive
system that aids in fertilization and surrounds
the upper portion of the urethra
• Prostate cancer occurs when uncontrolled
replication and metastasis of prostate cells
occur
• Cancer can occur from cells with damaged
cell-cycle checkpoints and adhesion
Background Cont…
• Cells become malignant and metastasize if they
can detach from the original tumor and invade
other tissues
• Cells divide in response to signals from other cells
know as “social control”
• Social control of the cell cycle is based on growth
factors
• Cancer cells can replicate in the absence of
growth factors because the cell cycle checkpoints
are damaged
Secretory Tissue
Mesenchymal Cellshttp://www.hindawi.com/journals/pc/2011/27
0403/fig5/
Background Cont…
• Cytokines and growth factors regulate growth
of cells and contribute to the
microenvironment
• TGFb is an important growth factor previously
shown to cause phenoconversion of
mesenchymal fibroblasts to myofibroblasts
• Myofibroblasts synthesize collagen and alpha
smooth muscle actin
Aim
• To see if a fibrotic microenvironment has an
effect on the proliferation of adjacent cancer
cells.
Hypothesis:
-Conditioned media from TGFb treated
fibroblasts will increase prostate cancer cell
proliferation
I. WST Assay Protocol Standardization
• A colorimetric assay for quantification of cell
proliferation in response to growth factors
• WST Reagent breaks down in the presence of
cellular enzymes into a colored product that
you can measure
– More cells=More Enzyme=Darker Color=Higher V
Standardization WST Assay: N1 cells, Mean value at three time
points
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
5K cells
FoldoverSF
Expt 2: Reading at 24hrs
30min
60min
120min
10k cells
24 hr SF 5k HIE
5k
SF
10
HIE
10
30 min avg 0.2265 0.3199 0.6376 0.4664
stdev 0.03343 0.0229 0.1090 0.0790
fold 1 1.4119 1 0.7316
60 min avg 0.3764 0.5702 1.1360 0.8594
stdev 0.0591 0.0433
0.1504
8 0.1457
fold 1 1.5145 1 0.7564
120
min avg 0.6740 0.983 1.9451 1.4700
stdev 0.1874 0.0846 0.2430 0.2145
fold 1 1.4584 1 0.7557
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
5K cells
FoldoverSF
60 min WST reading
24h
48hr
72h
10k cells
60 SF
24hr Avg 0.2521 0.389 0.3976 0.3035
Stdev 0.0065 0.0120 0.0126 0.0239
fold 1 1.5425 1 0.7632
48hr avg 0.3571 0.5417 0.3917 0.5255
stdev 0.0229 0.0121 0.0237 0.0181
fold 1 1.5167 1 1.3415
72hr avg 0.4345 0.5407 0.4372 0.5203
stdev 0.0497 0.0184 0.0224 0.0349
fold 1 1.2442 1 1.1900
Standardization WST Assay: N1 cells, Mean value at three culture
durations
WST Assay: PC3 Cancer Cell Standardization
0
0.5
1
1.5
2
2.5
3
5K 10K
FoldoverSF
7.9.12: 60 min reading
24hr 48hr
24h 60min SF 5k 10% 5k SF 10k 10% 10k
avg 0.3876 0.6651 0.5004 1.2783
stdev 0.01320 0.0527 0.01390 0.2658
fold 1 1.7159 1 2.5545
Media AVG STDEV FOLD
SF RPMI 0.22705 0.01704 1
10% RPMI 0.439025 0.07181 1.9336
II. Preparation of Conditioned Media
• N1 Fibroblasts cultured in small
dishes to 80% confluence
• Changed media to SF HIE for 24
hr
• Then treated the cells with
2ng/ml, 4ng/ml TGFB or Control
for 24 and 48hr
• Harvested the conditioned media
and froze it
III. Effect of Fibroblast conditioned
media on PC3 cancer cell proliferation
– Hemocytometer Count
– 700k cells/ml
– 1 ml cells +13 ml 10% RPMI 1:14 Dilution
– Cell suspension spun down and re-suspended in same
amount of conditioned media, SF HIE and 10% RPMI
– Plated 50k cells/well in a 96 well plate
– Incubated the cells for 24hr
– Performed WST assay
0
0.2
0.4
0.6
0.8
1
1.2
1.4
2ng/ml 4ng/ml 2ng/ml 4ng/ml 2ng/ml 4ng/ml
FoldoverUTConditionMedia
30min 60min 90min
24h
48h
Results: PC3 WST Assay with N1 condition media set 1
TGFb treated Condition Media
Percent Increase in WST Assay Normalize to UT 24h
-10.0%
-5.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
UT 2ng/ml 4ng/ml
24 hr
48 hr
5k cells #1 #3 #5 #7 #9 #11
SF RPMI 10% RPMI SF HIE Set 1: SF HIE condition media from N1 treated or not with TGFb
24hr treated 48hrhr treated
UT 2ng/ml 4ng/ml UT 2ng/ml 4ng/ml
Avg 0.172 0.3515 0.1249 0.1869 0.208 0.2015 0.1852 0.2369 0.2128
stdev 0.00513 0.04268 0.04096 0.0119 0.00901 0.0572 0.0154 0.0206 0.01465
Fold 1 2.03930 1 1.11237 1.0776 1 1.2794 1.1492
Control: Effect of TGFb on PC3 Cancer Cell Proliferation
• To make sure that the residual TGFb in the conditioned
media was not the cause of the increased proliferation of
PC3 cells in the prior experiment
– Grew PC3 Cancer Cells to 80% Confluence
– Trypsinize and count via Heamocytometer
– 700k cells/ml
– 1ml cells+13 ml of 10% RPMI 1:14 dilution
– 2ml of solution for 10%, 8ml for SF Control and TGFb treatment
– Plate control SF with 2 uL of Citric Acid, 2 ng/ml and 4ng/ml of
TGFb
0
0.5
1
1.5
2
2.5
FOLDOverSF
SF 10 2ul/ml CA 2ng/ml 4ng/ml
PC3 WST Assay: 24 hr TGFB Treatment
5k SF 10% 2 ul/ml
Citric
2 ng/ml
TGFb
4 ng/ml
TGFb
AVG 0.35665 0.705335 0.2758 0.2743 0.3136
STDEV 0.0283 0.07009 0.0326 0.01568 0.01866
Fold Over SF
RPMI 1 1.9776 0.7734 0.76931 0.8793
Conclusion
FAK
TGFb
Prostate cancer cell
ECM
Increases:
cell migration
Proliferation
ECM & Growth factors
Future Directions
• Both these experiments could be completed again!
• A scratch assay or well assay could be completed to
determine an increase in the motility of the cancer
cells with or without conditioned media!
• Focal Adhesion Kinases could be blocked in a PC3
conditioned media well or WST assay to see its role in
the cells motility and proliferation
• If (FAK) did not increase proliferation or motility a
protein lysate could be used to determine what type of
growth factors myofibroblasts synthesize into their
environment. Potentially IGF-1?
Acknowledgements
• Dr. Jill Macoska
• Dr. Nazy Kermani
• Sathish Kasina
• Jose Rodriguez-Nieves
THANK YOU!

More Related Content

Viewers also liked

Electrical Measurment Safety
Electrical Measurment SafetyElectrical Measurment Safety
Electrical Measurment SafetyFlukeMalta
 
ttopstart ERC Consolidator Grant (CoG) training - December 2015
ttopstart ERC Consolidator Grant (CoG) training - December 2015ttopstart ERC Consolidator Grant (CoG) training - December 2015
ttopstart ERC Consolidator Grant (CoG) training - December 2015ttopstart B.V.
 
Tiga Earth Mat Presentation
Tiga Earth Mat Presentation Tiga Earth Mat Presentation
Tiga Earth Mat Presentation SOURAV GHOSH
 
Illiteracy in pakistan
Illiteracy in pakistanIlliteracy in pakistan
Illiteracy in pakistanFalak Malik
 
Joints structure and classification
Joints structure and classification Joints structure and classification
Joints structure and classification trieducation
 

Viewers also liked (8)

resume 2
resume 2resume 2
resume 2
 
Electrical Measurment Safety
Electrical Measurment SafetyElectrical Measurment Safety
Electrical Measurment Safety
 
ttopstart ERC Consolidator Grant (CoG) training - December 2015
ttopstart ERC Consolidator Grant (CoG) training - December 2015ttopstart ERC Consolidator Grant (CoG) training - December 2015
ttopstart ERC Consolidator Grant (CoG) training - December 2015
 
Tiga Earth Mat Presentation
Tiga Earth Mat Presentation Tiga Earth Mat Presentation
Tiga Earth Mat Presentation
 
Cell & tissue nursing
Cell & tissue nursingCell & tissue nursing
Cell & tissue nursing
 
Illiteracy in pakistan
Illiteracy in pakistanIlliteracy in pakistan
Illiteracy in pakistan
 
Joints structure and classification
Joints structure and classification Joints structure and classification
Joints structure and classification
 
Types of Joints
Types of JointsTypes of Joints
Types of Joints
 

Similar to MacoskaLabFinal

SFB Denver Presentation
SFB Denver PresentationSFB Denver Presentation
SFB Denver PresentationAmanda Powell
 
multiplemyeloma-200929172223 (2).pdf
multiplemyeloma-200929172223 (2).pdfmultiplemyeloma-200929172223 (2).pdf
multiplemyeloma-200929172223 (2).pdfVaraprasadArigela
 
Tea against Cancer
Tea against CancerTea against Cancer
Tea against Cancerharen123
 
Lecture 9 (biol3600) genetics of cancer, population genetics
Lecture 9 (biol3600) genetics of cancer, population geneticsLecture 9 (biol3600) genetics of cancer, population genetics
Lecture 9 (biol3600) genetics of cancer, population geneticsPaula Faria Waziry
 
Slides faod - the other mitochondrial energy diseases - vockley
Slides   faod - the other mitochondrial energy diseases - vockleySlides   faod - the other mitochondrial energy diseases - vockley
Slides faod - the other mitochondrial energy diseases - vockleymitoaction
 
12. Cell synchronization and Immortalization
12. Cell synchronization and Immortalization12. Cell synchronization and Immortalization
12. Cell synchronization and ImmortalizationShailendra shera
 
NK-cell therapy for Hematologic Malignancies. Prof. Akihiro Shimosaka
NK-cell therapy for Hematologic Malignancies. Prof. Akihiro ShimosakaNK-cell therapy for Hematologic Malignancies. Prof. Akihiro Shimosaka
NK-cell therapy for Hematologic Malignancies. Prof. Akihiro Shimosakaspa718
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...MilliporeSigma
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Merck Life Sciences
 
Anticancer drug screening
Anticancer drug screeningAnticancer drug screening
Anticancer drug screeningshishirkawde
 
Cell cycle and therapeutic implications
Cell cycle and therapeutic implications Cell cycle and therapeutic implications
Cell cycle and therapeutic implications Priyanka Malekar
 
Cell cycle and carcinogenesis by Hussein Sabit
Cell cycle and carcinogenesis by Hussein SabitCell cycle and carcinogenesis by Hussein Sabit
Cell cycle and carcinogenesis by Hussein SabitHussein Sabit
 

Similar to MacoskaLabFinal (20)

SFB Denver Presentation
SFB Denver PresentationSFB Denver Presentation
SFB Denver Presentation
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
multiplemyeloma-200929172223 (2).pdf
multiplemyeloma-200929172223 (2).pdfmultiplemyeloma-200929172223 (2).pdf
multiplemyeloma-200929172223 (2).pdf
 
TaylorBMESPoster2016_v5
TaylorBMESPoster2016_v5TaylorBMESPoster2016_v5
TaylorBMESPoster2016_v5
 
Tea against Cancer
Tea against CancerTea against Cancer
Tea against Cancer
 
Land mark trials gastric cancer
Land mark trials gastric cancerLand mark trials gastric cancer
Land mark trials gastric cancer
 
Lecture 9 (biol3600) genetics of cancer, population genetics
Lecture 9 (biol3600) genetics of cancer, population geneticsLecture 9 (biol3600) genetics of cancer, population genetics
Lecture 9 (biol3600) genetics of cancer, population genetics
 
Thompson opac2013
Thompson opac2013Thompson opac2013
Thompson opac2013
 
Cell lines Basics
Cell lines BasicsCell lines Basics
Cell lines Basics
 
Cancer genetics
Cancer genetics Cancer genetics
Cancer genetics
 
Slides faod - the other mitochondrial energy diseases - vockley
Slides   faod - the other mitochondrial energy diseases - vockleySlides   faod - the other mitochondrial energy diseases - vockley
Slides faod - the other mitochondrial energy diseases - vockley
 
12. Cell synchronization and Immortalization
12. Cell synchronization and Immortalization12. Cell synchronization and Immortalization
12. Cell synchronization and Immortalization
 
NK-cell therapy for Hematologic Malignancies. Prof. Akihiro Shimosaka
NK-cell therapy for Hematologic Malignancies. Prof. Akihiro ShimosakaNK-cell therapy for Hematologic Malignancies. Prof. Akihiro Shimosaka
NK-cell therapy for Hematologic Malignancies. Prof. Akihiro Shimosaka
 
Leukemia case answer
Leukemia case answerLeukemia case answer
Leukemia case answer
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...
 
Anticancer drug screening
Anticancer drug screeningAnticancer drug screening
Anticancer drug screening
 
Cell cycle and therapeutic implications
Cell cycle and therapeutic implications Cell cycle and therapeutic implications
Cell cycle and therapeutic implications
 
Cell cycle and carcinogenesis by Hussein Sabit
Cell cycle and carcinogenesis by Hussein SabitCell cycle and carcinogenesis by Hussein Sabit
Cell cycle and carcinogenesis by Hussein Sabit
 
Seminario
SeminarioSeminario
Seminario
 

MacoskaLabFinal

  • 1. The effects of a fibrotic microenvironment on the proliferation of prostate cancer cells. Brad Christman Macoska Lab
  • 2. Background • Prostate is a part of the male reproductive system that aids in fertilization and surrounds the upper portion of the urethra • Prostate cancer occurs when uncontrolled replication and metastasis of prostate cells occur • Cancer can occur from cells with damaged cell-cycle checkpoints and adhesion
  • 3. Background Cont… • Cells become malignant and metastasize if they can detach from the original tumor and invade other tissues • Cells divide in response to signals from other cells know as “social control” • Social control of the cell cycle is based on growth factors • Cancer cells can replicate in the absence of growth factors because the cell cycle checkpoints are damaged
  • 5. Background Cont… • Cytokines and growth factors regulate growth of cells and contribute to the microenvironment • TGFb is an important growth factor previously shown to cause phenoconversion of mesenchymal fibroblasts to myofibroblasts • Myofibroblasts synthesize collagen and alpha smooth muscle actin
  • 6. Aim • To see if a fibrotic microenvironment has an effect on the proliferation of adjacent cancer cells. Hypothesis: -Conditioned media from TGFb treated fibroblasts will increase prostate cancer cell proliferation
  • 7. I. WST Assay Protocol Standardization • A colorimetric assay for quantification of cell proliferation in response to growth factors • WST Reagent breaks down in the presence of cellular enzymes into a colored product that you can measure – More cells=More Enzyme=Darker Color=Higher V
  • 8. Standardization WST Assay: N1 cells, Mean value at three time points 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 5K cells FoldoverSF Expt 2: Reading at 24hrs 30min 60min 120min 10k cells 24 hr SF 5k HIE 5k SF 10 HIE 10 30 min avg 0.2265 0.3199 0.6376 0.4664 stdev 0.03343 0.0229 0.1090 0.0790 fold 1 1.4119 1 0.7316 60 min avg 0.3764 0.5702 1.1360 0.8594 stdev 0.0591 0.0433 0.1504 8 0.1457 fold 1 1.5145 1 0.7564 120 min avg 0.6740 0.983 1.9451 1.4700 stdev 0.1874 0.0846 0.2430 0.2145 fold 1 1.4584 1 0.7557
  • 9. 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 5K cells FoldoverSF 60 min WST reading 24h 48hr 72h 10k cells 60 SF 24hr Avg 0.2521 0.389 0.3976 0.3035 Stdev 0.0065 0.0120 0.0126 0.0239 fold 1 1.5425 1 0.7632 48hr avg 0.3571 0.5417 0.3917 0.5255 stdev 0.0229 0.0121 0.0237 0.0181 fold 1 1.5167 1 1.3415 72hr avg 0.4345 0.5407 0.4372 0.5203 stdev 0.0497 0.0184 0.0224 0.0349 fold 1 1.2442 1 1.1900 Standardization WST Assay: N1 cells, Mean value at three culture durations
  • 10. WST Assay: PC3 Cancer Cell Standardization 0 0.5 1 1.5 2 2.5 3 5K 10K FoldoverSF 7.9.12: 60 min reading 24hr 48hr 24h 60min SF 5k 10% 5k SF 10k 10% 10k avg 0.3876 0.6651 0.5004 1.2783 stdev 0.01320 0.0527 0.01390 0.2658 fold 1 1.7159 1 2.5545 Media AVG STDEV FOLD SF RPMI 0.22705 0.01704 1 10% RPMI 0.439025 0.07181 1.9336
  • 11. II. Preparation of Conditioned Media • N1 Fibroblasts cultured in small dishes to 80% confluence • Changed media to SF HIE for 24 hr • Then treated the cells with 2ng/ml, 4ng/ml TGFB or Control for 24 and 48hr • Harvested the conditioned media and froze it
  • 12. III. Effect of Fibroblast conditioned media on PC3 cancer cell proliferation – Hemocytometer Count – 700k cells/ml – 1 ml cells +13 ml 10% RPMI 1:14 Dilution – Cell suspension spun down and re-suspended in same amount of conditioned media, SF HIE and 10% RPMI – Plated 50k cells/well in a 96 well plate – Incubated the cells for 24hr – Performed WST assay
  • 13. 0 0.2 0.4 0.6 0.8 1 1.2 1.4 2ng/ml 4ng/ml 2ng/ml 4ng/ml 2ng/ml 4ng/ml FoldoverUTConditionMedia 30min 60min 90min 24h 48h Results: PC3 WST Assay with N1 condition media set 1 TGFb treated Condition Media
  • 14. Percent Increase in WST Assay Normalize to UT 24h -10.0% -5.0% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% UT 2ng/ml 4ng/ml 24 hr 48 hr
  • 15. 5k cells #1 #3 #5 #7 #9 #11 SF RPMI 10% RPMI SF HIE Set 1: SF HIE condition media from N1 treated or not with TGFb 24hr treated 48hrhr treated UT 2ng/ml 4ng/ml UT 2ng/ml 4ng/ml Avg 0.172 0.3515 0.1249 0.1869 0.208 0.2015 0.1852 0.2369 0.2128 stdev 0.00513 0.04268 0.04096 0.0119 0.00901 0.0572 0.0154 0.0206 0.01465 Fold 1 2.03930 1 1.11237 1.0776 1 1.2794 1.1492
  • 16. Control: Effect of TGFb on PC3 Cancer Cell Proliferation • To make sure that the residual TGFb in the conditioned media was not the cause of the increased proliferation of PC3 cells in the prior experiment – Grew PC3 Cancer Cells to 80% Confluence – Trypsinize and count via Heamocytometer – 700k cells/ml – 1ml cells+13 ml of 10% RPMI 1:14 dilution – 2ml of solution for 10%, 8ml for SF Control and TGFb treatment – Plate control SF with 2 uL of Citric Acid, 2 ng/ml and 4ng/ml of TGFb
  • 17. 0 0.5 1 1.5 2 2.5 FOLDOverSF SF 10 2ul/ml CA 2ng/ml 4ng/ml PC3 WST Assay: 24 hr TGFB Treatment 5k SF 10% 2 ul/ml Citric 2 ng/ml TGFb 4 ng/ml TGFb AVG 0.35665 0.705335 0.2758 0.2743 0.3136 STDEV 0.0283 0.07009 0.0326 0.01568 0.01866 Fold Over SF RPMI 1 1.9776 0.7734 0.76931 0.8793
  • 18. Conclusion FAK TGFb Prostate cancer cell ECM Increases: cell migration Proliferation ECM & Growth factors
  • 19. Future Directions • Both these experiments could be completed again! • A scratch assay or well assay could be completed to determine an increase in the motility of the cancer cells with or without conditioned media! • Focal Adhesion Kinases could be blocked in a PC3 conditioned media well or WST assay to see its role in the cells motility and proliferation • If (FAK) did not increase proliferation or motility a protein lysate could be used to determine what type of growth factors myofibroblasts synthesize into their environment. Potentially IGF-1?
  • 20. Acknowledgements • Dr. Jill Macoska • Dr. Nazy Kermani • Sathish Kasina • Jose Rodriguez-Nieves